New Jersey Doctor Charged with Medical Fraud and Sexual Assault

In a shocking case that has sent ripples through the medical community, Dr. Ritesh Kalra, an Indian-origin physician practicing in New Jersey, faces multiple charges including medical fraud and sexual assault. The allegations against him, detailed in a Department of Justice (DOJ) announcement on July 19, 2025, include unlawfully distributing opioids and soliciting sexual favors from patients in exchange for prescriptions.

According to the DOJ, Dr. Kalra allegedly operated a pill mill out of his medical office, prescribing high doses of opioids, including oxycodone, without any legitimate medical purpose. Between January 2019 and February 2025, he reportedly issued over 31,000 prescriptions for oxycodone, with some days seeing him write as many as 50 prescriptions. This pattern of behavior raises serious questions about the integrity of medical practices in the area.

Dr. Kalra's actions are not only a breach of ethical standards but also an egregious example of exploitation in the healthcare sector. Alina Habba, the U.S. Attorney for the District of New Jersey, commented on the case, stating, "Physicians hold a position of profound responsibility—but as alleged, Dr. Kalra used that position to fuel addiction, exploit vulnerable patients for sex, and defraud New Jersey’s public healthcare program."

The allegations extend beyond mere fraud; former employees and patients have come forward with claims that Dr. Kalra solicited sexual favors from female patients. Some women reported that he touched them inappropriately during appointments and demanded sexual acts in exchange for prescriptions. One patient even alleged that she was coerced into performing sexual acts during her clinical visits. These accusations suggest a deeply troubling pattern of abuse of power and trust within a healthcare setting.

Additionally, Dr. Kalra is accused of submitting false claims for in-person visits that never occurred. His electronic medical records reportedly contained fabricated progress notes, with examination notes that were identical across multiple visits and did not accurately reflect patient conditions. This fraudulent activity raises significant concerns regarding the integrity of billing practices in the healthcare industry.

The implications of this case are far-reaching. It highlights the urgent need for stricter regulations and oversight in the medical field, particularly concerning opioid prescriptions. According to the National Institute on Drug Abuse, the opioid epidemic has led to over 500,000 deaths in the U.S. since 1999, and cases like Dr. Kalra's exemplify the dangers posed by unscrupulous medical practitioners.

Experts in the field are calling for a comprehensive review of existing policies governing prescription practices. Dr. Amy Thompson, an addiction specialist and Professor of Psychiatry at Johns Hopkins University, stated, "This case underscores the critical need for continuous training and monitoring of healthcare providers, especially those handling controlled substances."

The repercussions for Dr. Kalra are severe; he is currently under home arrest, prohibited from practicing medicine, and required to shut down his medical practice while the case proceeds. This legal action serves as a reminder that the healthcare system must prioritize patient safety and ethical standards above all else.

As the investigation unfolds, it remains to be seen how this case will influence future policies and practices within the healthcare sector. The need for vigilance and accountability is more crucial than ever as communities grapple with the ongoing impact of the opioid crisis and the importance of trust in medical professionals.